Leukemia, Plasma Cell
Showing 9926 - 9950 of >10,000
Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)
Active, not recruiting
- Gaucher Disease Type 1
- Gaucher Disease Type 3
- venglustat (GZ402671)
- imiglucerase
-
New Haven, Connecticut
- +6 more
Aug 9, 2022
Corneal Perforation Trial in Minya (Platelet rich plasma clot implantation, Wound closure with amniotic membrane)
Completed
- Corneal Perforation
- Platelet rich plasma clot implantation
- Wound closure with amniotic membrane
-
Minya, EgyptFaculty of Medicine
May 17, 2021
Nutritional Requirements Trial in Columbus (Zero hard-boiled egg at 0 h, One hard-boiled egg at 0 h, Two hard-boiled eggs at 0
Recruiting
- Nutritional Requirements
- Zero hard-boiled egg at 0 h
- +5 more
-
Columbus, OhioOhio State University
Dec 16, 2022
MDS, Leukemia, Myelomonocytic, Chronic Trial in France, Germany (Azacitidine, Volasertib)
Terminated
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
-
Marseille, France
- +13 more
Sep 11, 2018
Dyslipidemias, Obesity Trial in Washington (Alive-Family)
Active, not recruiting
- Dyslipidemias
- Obesity
- Alive-Family
-
Washington, District of ColumbiaChildrens National Hospital
Feb 3, 2022
Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU of Nantes
Dec 16, 2022
Heart Transplantation Trial in Madrid (Autologous thyTreg)
Recruiting
- Heart Transplantation
- Autologous thyTreg
-
Madrid, SpainHospital General Universitario Gregorio Marañon
Dec 5, 2022
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Association Between Telomere Length and Cardiac Dysfunction
Completed
- Cardiac Toxicity
- +2 more
- Relative telomere length
-
Tianjin, Tianjin, ChinaXiao-Fan Zhu
May 27, 2020
Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,
Completed
- Metastatic Renal Cell Carcinoma
- +4 more
- HyperAcute®-Renal (HAR) Immunotherapy
-
Iowa City, Iowa
- +2 more
Apr 4, 2022
NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- MPDL3280A
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 12, 2022
Non-ischemic Dilated Cardiomyopathy Trial in United States (allogeneic human mesenchymal stem cells (hMSCs), Placebo)
Recruiting
- Non-ischemic Dilated Cardiomyopathy
- allogeneic human mesenchymal stem cells (hMSCs)
- Placebo
-
Stanford, California
- +3 more
Mar 23, 2022
Neuropathic Pain, Chronic Postsurgical Pain Trial in Strasbourg (Treatment)
Recruiting
- Neuropathic Pain
- Chronic Postsurgical Pain
- Treatment
-
Strasbourg, Bas-Rhin, FranceLes Hôpitaux Universitaires
Feb 24, 2022
Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18) Trial in Boston (vitamin D3, omega-3 fatty acids (fish oil),
Active, not recruiting
- Infections
- Human Cathelicidin Antimicrobial Peptide (hCAP-18)
- vitamin D3
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 10, 2022
Foot, Diabetic Trial in Córdoba (Personalized Nutritional Intervention)
Not yet recruiting
- Foot, Diabetic
- Personalized Nutritional Intervention
-
Córdoba, Andalucía, SpainHospital Universitario Reina Sofía de Córdoba
Aug 4, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)
Recruiting
- Multiple Sclerosis, Primary Progressive
- Ocrelizumab
- Placebo
-
Scottsdale, Arizona
- +197 more
Jan 2, 2023
Oral Mucositis, Hematopoietic Tumor, Xerostomia Trial in Porto Alegre (Photobiomodulation therapy (intraoral),
Recruiting
- Oral Mucositis
- +3 more
- Photobiomodulation therapy (intraoral)
- Photobiomodulation therapy (extraoral)
-
Porto Alegre, Rio Grande Do Sul, BrazilFederal University of Rio Grande do Sul
Mar 7, 2023
Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)
Recruiting
- Thrombotic Microangiopathy
- Ravulizumab
- +2 more
-
Tampa, Florida
- +90 more
Jan 26, 2023
Heart Failure Trial in Grand Rapids
Recruiting
- Heart Failure
-
Grand Rapids, MichiganFrederik Meijer Heart Center
Nov 23, 2022
Allogeneic Gamma Delta (?d) CAR T Cells
Enrolling by invitation
- Lymphoma, Follicular
- +5 more
- ADI-001
-
Stanford, California
- +4 more
Jun 7, 2022